Axonics Modulation Technologies/AXNX

$67.51

-0.24%
-
1D1W1MYTD1YMAX

About Axonics Modulation Technologies

Axonics, Inc. is a medical technology company, which develops and commercializes products to treat adults with bladder and bowel dysfunction. The Company has designed and developed both rechargeable (R20) and recharge-free (F15) implantable sacral neuromodulation (SNM) systems, which deliver mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder (OAB), urinary retention (UR) and fecal incontinence (FI). The recharge-free implantable neurostimulator (INS) is approximately 10cc in volume, utilizes constant current stimulation, an easy-to-use, intuitive recharge-free patient remote control and other related accessories. It engineered its recharge-free sacral neuromodulation (SNM) system to deliver constant-current stimulation. Its SNM system includes an easy-to-use wireless patient remote control that does not require recharging or replacement batteries.

Ticker

AXNX

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Raymond Cohen

Employees

797

Headquarters

Irvine, United States

AXNX Metrics

BasicAdvanced
$3.5B
Market cap
-
P/E ratio
-$0.31
EPS
0.91
Beta
-
Dividend rate
$3.5B
0.90501
$69.68
$47.59
777K
9.962
8.036
-2.31%
-2.65%
-2.52%
8.92
5.507
7.672
30.82%
68.48%
48.65%

What the Analysts think about AXNX

Analyst Ratings

Majority rating from 14 analysts.
Hold

Price Targets

Average projection from 11 analysts.
6.25% upside
High $75.00
Low $71.00
$67.51
Current price
$71.73
Average price target

AXNX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-20.89% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$91M
-16.68%
Net income
-$19M
-393.85%
Profit margin
-20.89%
-452.87%

AXNX Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 352.38%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.15
$0.08
$0.13
-$0.38
-
Expected
-$0.11
-$0.06
$0.06
-$0.08
$0.12
Surprise
32%
-245.45%
123.37%
352.38%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Axonics Modulation Technologies stock?

Axonics Modulation Technologies (AXNX) has a market cap of $3.4B as of May 20, 2024.

What is the P/E ratio for Axonics Modulation Technologies stock?

The price to earnings (P/E) ratio for Axonics Modulation Technologies (AXNX) stock is 0 as of May 20, 2024.

Does Axonics Modulation Technologies stock pay dividends?

No, Axonics Modulation Technologies (AXNX) stock does not pay dividends to its shareholders as of May 20, 2024.

When is the next Axonics Modulation Technologies dividend payment date?

Axonics Modulation Technologies (AXNX) stock does not pay dividends to its shareholders.

What is the beta indicator for Axonics Modulation Technologies?

Axonics Modulation Technologies (AXNX) has a beta rating of 0.9. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Axonics Modulation Technologies stock price target?

The target price for Axonics Modulation Technologies (AXNX) stock is $71.73, which is 6.19% above the current price of $67.55. This is an average based on projections from 11 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Axonics Modulation Technologies stock

Buy or sell Axonics Modulation Technologies stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing